MRX

Pharmaceuticals, namely, live biotherapeutics for the treatment of cancer, brain injuries, central nervous system disorders, bowel disorders, lung disorders and diseases, and inflammatory and autoimmune diseases; live biotherapeutic bacterial formulations for medical use, namely, the treatment of cancer, brain injuries, central nervous system disorders, bowel disorders, lung disorders and diseases, and inflammatory and autoimmune diseases; preparations of microorganisms for medical use